Literature DB >> 9385376

Clinical and genetic heterogeneity in Meckel syndrome.

P Paavola1, R Salonen, A Baumer, A Schinzel, P A Boyd, S Gould, H Meusburger, R Tenconi, A Barnicoat, R Winter, L Peltonen.   

Abstract

Meckel syndrome (MKS) is a lethal malformation syndrome characterised by posterior meningoencephalocele, polycystic kidneys, fibrotic changes of the liver, and polydactyly. We have previously shown a linkage to chromosome 17q in 17 Finnish Meckel families. In this study we have analysed one Italian, one Austrian (of Turkish origin) and three British MKS families (Caucasian, Pakistani, and Bangladeshi families) for linkage to the MKS locus on chromosome 17q22-q24. We did not observe co-segregation of the disease and marker haplotypes in the Austrian family or in the three British families, of which two represented classical MKS and one a slightly atypical MKS phenotype with longer survival of the patient. In the Italian family the affected and non-affected children did not share the same maternal chromosome and thus this family could represent the same allelic disease as the Finnish MKS families. These results suggest locus heterogeneity in Meckel syndrome--a feature previously suspected based on the highly variable clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385376     DOI: 10.1007/s004390050592

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

1.  Antenatal expression of multiple acyl-CoA dehydrogenase deficiency.

Authors:  C Vianey-Saban; R Bouvier; P Cochat; A Buenerd; P Divry; R Dumoulin; M P Cordier
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

Review 2.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

3.  Prenatal diagnosis of Meckel-Gruber syndrome in a pregnancy obtained with ICSI.

Authors:  Claudio Celentano; Federico Prefumo; Marco Liberati; Giuseppina Gallo; Quirino Di Nisio; Sigfried Rotmensch
Journal:  J Assist Reprod Genet       Date:  2006-06-21       Impact factor: 3.412

4.  Clinical utility gene card for: Meckel syndrome.

Authors:  R Salonen; M Kestilä; C Bergmann
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

5.  Clinical utility gene card for: Meckel syndrome - update 2016.

Authors:  Carsten Bergmann; Valeska Frank; Riitta Salonen
Journal:  Eur J Hum Genet       Date:  2016-04-20       Impact factor: 4.246

6.  Molecular diagnostics of Meckel-Gruber syndrome highlights phenotypic differences between MKS1 and MKS3.

Authors:  Mark B Consugar; Vickie J Kubly; Donna J Lager; Cynthia J Hommerding; Wai Chong Wong; Egbert Bakker; Vincent H Gattone; Vicente E Torres; Martijn H Breuning; Peter C Harris
Journal:  Hum Genet       Date:  2007-03-22       Impact factor: 4.132

7.  Meckel-Gruber Syndrome: a population-based study on prevalence, prenatal diagnosis, clinical features, and survival in Europe.

Authors:  Ingeborg Barisic; Ljubica Boban; Maria Loane; Ester Garne; Diana Wellesley; Elisa Calzolari; Helen Dolk; Marie-Claude Addor; Jorieke Eh Bergman; Paula Braz; Elizabeth S Draper; Martin Haeusler; Babak Khoshnood; Kari Klungsoyr; Anna Pierini; Annette Queisser-Luft; Judith Rankin; Anke Rissmann; Christine Verellen-Dumoulin
Journal:  Eur J Hum Genet       Date:  2014-09-03       Impact factor: 4.246

Review 8.  Meckel syndrome.

Authors:  R Salonen; P Paavola
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

9.  Mutation spectrum of Meckel syndrome genes: one group of syndromes or several distinct groups?

Authors:  Jonna Tallila; Riitta Salonen; Nicolai Kohlschmidt; Leena Peltonen; Marjo Kestilä
Journal:  Hum Mutat       Date:  2009-08       Impact factor: 4.878

10.  High-resolution physical and genetic mapping of the critical region for Meckel syndrome and Mulibrey Nanism on chromosome 17q22-q23.

Authors:  P Paavola; K Avela; N Horelli-Kuitunen; M Bärlund; A Kallioniemi; N Idänheimo; M Kyttälä; A de la Chapelle; A Palotie; A E Lehesjoki; L Peltonen
Journal:  Genome Res       Date:  1999-03       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.